Related Experiment Video
Updated: May 10, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Papillary thyroid microcarcinoma with and without nodal metastasis: A comparative analysis
Saleh Alqaryan1, Hisham Almousa1, Raed Almutairi1
1From the Otolaryngology - Head and Neck Surgery Department (Alqaryan, Almousa, Alessa, Aldhahri, Alqahtani), King Saud University; from the Otolaryngology - Head and Neck Surgery Division, Department of Surgery (Alqaryan), King Abdulaziz Medical City, National Guard for Health Affairs; from the Otolaryngology - Head and Neck Surgery Department (Almayouf, Albarrak), King Fahad Medical City; from the Otolaryngology - Head and Neck Surgery Department (Doubi), King Saud Medical City; from the Otolaryngology - Head and Neck Surgery Department (Altuwaijri), Security Forces Hospital; from the College of Medicine (Alqahtani), Imam Mohammad Ibn Saud Islamic University, Riyadh; and from the Otolaryngology - Head and Neck Surgery Department (Almutairi), King Fahad Specialist Hospital, Buraidah, Kingdom of Saudi Arabia.
Papillary thyroid microcarcinoma (PTMC) in Saudi Arabia shows a 9.17% lymph node metastasis (LNM) rate. Key risk factors for LNM include higher Bethesda class and extrathyroidal extension, informing clinical risk assessment.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Papillary thyroid microcarcinoma (PTMC) is frequently discovered incidentally.
- Despite small size, PTMC carries a notable risk of lymph node metastasis (LNM).
- Understanding PTMC demographics and LNM predictors is crucial for patient management.
Purpose of the Study:
- To evaluate the demographic and clinical characteristics of PTMC patients in Saudi Arabia.
- To identify factors associated with lymph node metastasis (LNM) in PTMC.
- To compare clinical differences between PTMC patients with and without LNM.
Main Methods:
- Retrospective analysis of PTMC patients undergoing surgery between 2012-2022.
- Inclusion of data from King Abdulaziz University Hospital, King Fahad Medical City, and King Abdulaziz Medical City.
- Statistical comparison of patient demographics and clinical factors based on LNM status.
Main Results:
- The overall incidence of LNM in PTMC patients was 9.17%.
- Significant risk factors for LNM included higher Bethesda class, specific pathology types, extrathyroidal extension, extracapsular extension, lymphovascular invasion, and residual tumors post-radioactive iodine therapy.
- Factors such as thyroiditis, multifocality, goiter, neural invasion, and tumor size were not significantly associated with LNM.
Conclusions:
- Higher Bethesda class, pathology type, extrathyroidal extension, extracapsular extension, lymphovascular invasion, and residual tumors after RAI treatment are strongly associated with LNM in PTMC.
- These findings aid in stratifying PTMC patients at higher risk for LNM.
- Further research may refine risk stratification and treatment strategies for PTMC.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

